Related Experiment Video
Updated: Jun 12, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Cyclooxygenase and atherosclerosis: a smoking area
F Pistoia1, F Cipollone, C Ferri
1Casa di Cura San Raffaele, via Gaetano di Biasio 1, 03043 Cassino (FR), Italia. pistoiafrancesca@hotmail.com
Current Pharmaceutical Design
|June 17, 2010
Summary
Chronic smoking accelerates atherosclerosis by promoting vascular inflammation and plaque instability. Cyclooxygenase-2 (COX-2) plays a key role in linking smoking to these detrimental vascular changes and acute ischemic events.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Pathophysiology
Background:
- Chronic smoking induces vascular inflammation, leading to atherosclerosis.
- Cyclooxygenase (COX) enzymes are crucial in mediating inflammatory processes linked to smoking.
- Two main isoenzymes, COX-1 and COX-2, exhibit distinct characteristics and roles.
Purpose of the Study:
- To review the role of chronic smoking in vascular dysfunction, inflammation, and lipid modification in atherosclerosis.
- To emphasize plaque composition over size in determining plaque rupture and acute ischemic syndromes.
- To highlight the link between smoking, COX-2, and matrix metalloproteinase (MMP) activity via prostaglandin E2 (PGE2).
Main Methods:
- Literature review focusing on the pathogenetic mechanisms of smoking-induced vascular damage.
- Analysis of the role of cyclooxygenase (COX) enzymes, particularly COX-2.
- Examination of the expression of EP4, COX-2, mPGES-1, MMP-2, and MMP-9 in unstable plaques.
Main Results:
- Chronic smoking contributes to vasomotor dysfunction, inflammation, and lipid alterations driving atherosclerosis.
- Plaque composition, rather than size, is a critical determinant of plaque rupture and acute ischemic events.
- Elevated expression of EP4, COX-2, mPGES-1, MMP-2, and MMP-9 is observed in unstable plaques.
Conclusions:
- COX-2 is a key enzyme linking smoking-induced inflammation to vascular damage and atherothrombosis.
- PGE2 acts as a crucial mediator connecting smoking, COX-2 activity, and MMPs in the context of atherothrombosis.
- Understanding these pathways is vital for clarifying the role of COX-2 in atherothrombosis and developing targeted therapies.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...